Valuation: Camurus AB

Market Cap 31.99B 3.3B 2.9B 2.68B 2.47B 4.67B 316B 4.76B 12.55B 155B 12.41B 12.13B 536B P/E 2026 *
36.2x
P/E 2027 * 22.5x
Enterprise Value 27.54B 2.84B 2.49B 2.31B 2.13B 4.02B 272B 4.1B 10.8B 134B 10.68B 10.45B 462B EV / Sales 2026 *
9.83x
EV / Sales 2027 * 6.97x
Free-Float
67.52%
Yield 2026 *
-
Yield 2027 * -
1 day-3.47%
1 week-7.25%
Current month-4.95%
1 month-1.92%
3 months+4.37%
6 months-21.36%
Current year-12.74%
1 week 531.5
Extreme 531.5
586
1 month 505
Extreme 505
590.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 272.2
Extreme 272.2
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap.
02-27Sell

Chief Executive Officer

9,950 0.0166%
02-27Sell

Chief Executive Officer

1,500 0.0025%
02-27Sell

Chief Executive Officer

55,550 0.0928%
Change 5-day change 1-year change 3-year change Capi.($)
-3.07%-7.25%-21.76%+96.60% 3.42B
-0.56%-1.52%+47.86%+171.88% 1,060B
+0.31%-0.60%+64.37%+62.31% 619B
-0.03%-2.65%+29.49%+85.64% 438B
-1.75%-0.33%+28.33%+23.58% 333B
+0.24%-0.42%+29.19%+47.26% 282B
-1.75%-10.57%+18.27%+22.07% 267B
+0.67%+1.03%-26.81%-37.96% 218B
-0.81%-1.63%+21.35%+58.33% 196B
+1.21%+1.38%+17.23%+71.29% 161B
Average -0.81%-3.32%+20.75%+60.10% 357.73B
Weighted average by Cap. -0.58%-3.10%+35.51%+83.95%

Financials

2026 *2027 *
Net sales 2.8B 289M 254M 235M 216M 409M 27.68B 417M 1.1B 13.59B 1.09B 1.06B 46.95B 3.76B 389M 341M 316M 291M 550M 37.21B 560M 1.48B 18.27B 1.46B 1.43B 63.11B
Net income 906M 93.56M 82.06M 76M 69.93M 132M 8.95B 135M 355M 4.4B 351M 344M 15.19B 1.45B 150M 131M 122M 112M 211M 14.32B 216M 568M 7.03B 562M 549M 24.28B
Net Debt -4.45B -459M -403M -373M -343M -649M -43.97B -662M -1.74B -21.59B -1.73B -1.69B -74.57B -5.74B -592M -520M -481M -443M -838M -56.71B -854M -2.25B -27.85B -2.22B -2.18B -96.17B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
308
Date Price Change Volume
13/07/26 SEK 537.50 -3.07% 72,062
10/07/26 SEK 554.50 +0.82% 101,864
09/07/26 SEK 550.00 -1.52% 95,389
08/07/26 SEK 558.50 -3.37% 76,734
07/07/26 SEK 578.00 -0.26% 76,010
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
554.50SEK
Average target price
768.12SEK
Spread / Average Target
+38.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock